X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (122) 122
clinical neurology (95) 95
adult (81) 81
male (80) 80
female (79) 79
magnetic resonance imaging (69) 69
index medicus (65) 65
multiple sclerosis (64) 64
middle aged (58) 58
brain - pathology (51) 51
neurosciences (36) 36
disability (34) 34
magnetic resonance imaging - methods (31) 31
disease progression (30) 30
multiple sclerosis - diagnosis (29) 29
mri (26) 26
adolescent (25) 25
multiple sclerosis - pathology (25) 25
disability evaluation (21) 21
double-blind (21) 21
neuroimaging (21) 21
follow-up studies (20) 20
guidelines (19) 19
treatment outcome (19) 19
sensitivity and specificity (18) 18
aged (17) 17
brain (17) 17
child (17) 17
neurology (17) 17
multiple-sclerosis (16) 16
predictive value of tests (16) 16
radiology, nuclear medicine & medical imaging (16) 16
longitudinal studies (15) 15
reproducibility of results (15) 15
severity of illness index (15) 15
time factors (15) 15
atrophy (14) 14
disease-activity (14) 14
prognosis (14) 14
young adult (14) 14
glatiramer acetate (13) 13
multiple sclerosis - drug therapy (13) 13
multiple sclerosis, relapsing-remitting - pathology (13) 13
retrospective studies (13) 13
risk factors (13) 13
child, preschool (12) 12
research (12) 12
abridged index medicus (11) 11
appearing white-matter (11) 11
care and treatment (11) 11
clinical trials (11) 11
diagnosis (11) 11
multicenter (11) 11
multiple sclerosis - physiopathology (11) 11
immunology (10) 10
impairment (10) 10
multiple sclerosis, relapsing-remitting - diagnosis (10) 10
multiple sclerosis, relapsing-remitting - drug therapy (10) 10
placebo-controlled trial (10) 10
recurrence (10) 10
abnormalities (9) 9
lesions (9) 9
multiple sclerosis - therapy (9) 9
spinal cord - pathology (9) 9
attenuated inversion-recovery (8) 8
brain - drug effects (8) 8
demyelination (8) 8
follow-up (8) 8
health aspects (8) 8
hypointense lesions (8) 8
immunosuppressive agents - therapeutic use (8) 8
nuclear magnetic resonance--nmr (8) 8
observer variation (8) 8
psychiatry (8) 8
rheumatology (8) 8
axonal loss (7) 7
brain atrophy (7) 7
diagnostic-criteria (7) 7
double-blind method (7) 7
interferon beta-1a (7) 7
italy (7) 7
magnetic-resonance (7) 7
multiple sclerosis, chronic progressive - diagnosis (7) 7
multiple sclerosis, chronic progressive - pathology (7) 7
progressive multiple-sclerosis (7) 7
studies (7) 7
surgery (7) 7
usage (7) 7
white-matter (7) 7
age (6) 6
age factors (6) 6
analysis (6) 6
brain - physiopathology (6) 6
brain damage (6) 6
case-control studies (6) 6
cohort studies (6) 6
gadolinium (6) 6
grey-matter (6) 6
image enhancement (6) 6
interferon-beta (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Neurology, ISSN 1759-4758, 2015, Volume 11, Issue 8, pp. 471 - 482
The clinical use of MRI in patients with multiple sclerosis (MS) has advanced markedly over the past few years. Technical improvements and continuously... 
SPINAL-CORD LESIONS | WHITE-MATTER LESIONS | BRAIN ATROPHY | ATTENUATED INVERSION-RECOVERY | MS LESIONS | NEUROMYELITIS-OPTICA | IN-VIVO | GADOLINIUM-ENHANCED MRI | MAGNETIZATION-TRANSFER | CLINICAL NEUROLOGY | 2010 MCDONALD CRITERIA | Practice guidelines (Medicine) | Multiple sclerosis | Diagnosis | Magnetic resonance imaging | Standards
Journal Article
Neurology, ISSN 0028-3878, 03/2008, Volume 70, Issue 12, p. 982
Journal Article
European Journal of Neurology, ISSN 1351-5101, 02/2018, Volume 25, Issue 2, pp. 215 - 237
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 6/2012, Volume 18, Issue 6, pp. 835 - 842
Background: Over recent years numerous patients with severe forms of multiple sclerosis (MS) refractory to conventional therapies have been treated with... 
haematopoietic stem cell transplantation | multiple sclerosis | bone marrow transplantation | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | BONE-MARROW-TRANSPLANTATION | DOSE IMMUNOSUPPRESSIVE THERAPY | EUROPEAN GROUP | SYSTEMIC-SCLEROSIS | NEUROSCIENCES | WORKING PARTY | CLINICAL NEUROLOGY | TRIAL | IMPACT | DISEASES | BLOOD | Predictive Value of Tests | Humans | Middle Aged | Transplantation, Autologous | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Hematopoietic Stem Cell Transplantation - mortality | Transplantation Conditioning - mortality | Young Adult | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Registries | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Multiple Sclerosis, Relapsing-Remitting - surgery | Disability Evaluation | Severity of Illness Index | Kaplan-Meier Estimate | Treatment Outcome | Multiple Sclerosis, Chronic Progressive - surgery | Chi-Square Distribution | Disease Progression | Disease-Free Survival | Magnetic Resonance Imaging | Multiple Sclerosis, Chronic Progressive - diagnosis | Multiple Sclerosis, Chronic Progressive - mortality | Adolescent | Multiple Sclerosis, Relapsing-Remitting - mortality | Italy | Autografts | Immunosuppression | Multiple sclerosis | Magnetic resonance imaging | Toxicity | stem cell transplantation | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 07/2010, Volume 75, Issue 4, pp. 302 - 309
Journal Article